Jiang Tongbo, Phelan Maurice
Millipore Corporation, 900 Middlesex Turnpike, Billerica, MA 01821, USA.
PDA J Pharm Sci Technol. 2003 Jul-Aug;57(4):287-99.
Drug manufacturers use filters widely in their manufacturing processes for bioburden reduction and sterility assurance. In implementing a pharmaceutical filtration, it is essential to determine and profile the filter extractables that could be introduced into the product. There is an ongoing industry effort to explore the analysis of extractables. Toward this end, the use of complementary analytical techniques was evaluated to aid in extractables identification by determining whether the analysis of filters in the form of components, rather than entire assemblies, facilitated the profiling of extractables. The study examines filter components of 10-inch, 0.22-microm Durapore cartridge filters using Fourier transform infra-red spectroscopy (FTIR) and nuclear magnetic resonance spectroscopy (NMR), as well as determines the non-volatile residues (NVR) and total organic carbon contents (TOC) of the extractables. The complementary techniques of high performance liquid chromatography (HPLC/UV) and liquid chromatography nuclear magnetic resonance spectroscopy (LC/NMR) were also used. The results of the tests indicated very low levels of extractables.
药品制造商在其生产过程中广泛使用过滤器,以减少生物负载并确保无菌。在实施药品过滤时,确定并分析可能引入产品中的过滤器可提取物至关重要。目前,行业内正在努力探索可提取物的分析方法。为此,评估了使用互补分析技术,通过确定以组件形式而非整个组件形式对过滤器进行分析是否有助于可提取物的分析,来辅助可提取物的鉴定。该研究使用傅里叶变换红外光谱(FTIR)和核磁共振光谱(NMR)检查了10英寸、0.22微米的Durapore滤芯过滤器的组件,并测定了可提取物的非挥发性残留物(NVR)和总有机碳含量(TOC)。还使用了高效液相色谱(HPLC/UV)和液相色谱核磁共振光谱(LC/NMR)等互补技术。测试结果表明可提取物的含量非常低。